Investors Land AQST Even Cheaper Than Its Secondary Stock Offering

Looking back to 2 days ago, Aquestive Therapeutics Inc (NASDAQ:AQST) priced a 16,666,667 share secondary stock offering at $4.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Thursday, bargain hunters could buy shares of AQST and achieve a cost basis 3.1% cheaper than those buyers, with shares changing hands as low as $4.36 per share.

Start slideshow:
All Recent Secondary Stock Offerings »

Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. At last check, Aquestive Therapeutics Inc shares are currently trading off about 15.6% on the day. The chart below shows the one year performance of AQST shares, versus its 200 day moving average:

Looking at the chart above, AQST's low point in its 52 week range is $0.782 per share, with $6.23 as the 52 week high point — that compares with a last trade of $4.45.